MyFinsight
Home
Blog
About
Back
Income Statement
Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS)
source: myfinsight.com
Net income (gain)
-$28,710K
(6.47%↑ Y/Y)
Dividend income
$2,287K
(-67.88%↓ Y/Y)
Income (gain) before
income taxes
-$28,710K
(12.78%↑ Y/Y)
Total other income,
net
$2,227K
(-67.72%↓ Y/Y)
Other expense, net
-$60K
(72.85%↑ Y/Y)
Income (gain) from
operations
-$30,937K
(22.30%↑ Y/Y)
Total operating
expenses
$30,937K
(-46.65%↓ Y/Y)
Research and development
$22,331K
(-48.67%↓ Y/Y)
General and
administrative
$8,606K
(-40.57%↓ Y/Y)
Back